June 23, 2015

Loma Lux Laboratories has unveiled new packaging that spotlights its patented, natural mineral technology formulations that, according to the company, have been clinically validated and dermatologist-developed to relieve the skin inflammatory disorders of acne, eczema and psoriasis.

June 15, 2015

Such chronic skin conditions as psoriasis and eczema have taken an anti-itch category known for its summertime seasonal sales spikes — because of such acute needs as poison ivy and bug bites — and have made it a year-round destination category.

June 15, 2015

Cosmederm Bioscience’s TriCalm OTC itch-relief solution was recognized in May by the journal Clinical, Cosmetic and Investigational Dermatology,, which published a study finding that Cosmederm’s solution was superior to diphenhydramine 2% and hydrocortisone 1%.

January 21, 2015

The Food and Drug Administration on Wednesday announced approval for Cosentyx (secukinumab), indicated for the treatment of adults with moderate to severe plaque psoriasis.


January 12, 2015

Perrigo on Monday announced that it has launched clobetasol propionate spray, 0.05%, the generic equivalent to Clobex spray, 0.05%. 

September 25, 2014

Celgene Corp. earlier this week announced that the Food and Drug Administration approved Otezla (apremilast) for the treatment of moderate to severe plaque psoriasis. The drug is the first and only PDE4 inhibitor approved for the treatment of plaque psoriasis, according to the company.

September 17, 2014

Out of Africa has expanded its portfolio with a new line of Whipped and Creamy Shea Body Butters in four all-natural scents: Vanilla, Lavender, Lemon Verbena and Pomegranate.

July 30, 2014

Perrigo on Wednesday announced that it has filed an abbreviated new drug application with the Food and Drug Administration for desoximetasone topical spray 0.25%. The company also has notified Taro Pharmaceuticals U.S.A., the owner of the reference listed drug, of the filing.

June 25, 2014

Quest Products has announced the national launch of its ProVent Eczema and Psoriasis Spray, a spray formulated to help minimize the appearance of skin conditions often associated with eczema and psoriasis.

June 11, 2014

Advanced Care Scripts, a division of Omnicare Specialty Care Group, on Wednesday announced that it has been added to the limited-distribution network for Celgene's Otezla (apremilast).

May 6, 2014

Sandoz recently announced that the generic manufacturer continues to advance its biosimilars pipeline that currently has six molecules in the Phase III clinical trial/filing prep phase.

April 8, 2014

Diplomat on Monday announced that it is one of a select group of specialty pharmacies contracted by Celgene to distribute Otezla (apremilast), a new medication for the treatment of psoriatic arthritis.

April 3, 2014

Axium Healthcare Pharmacy announced that it will begin to dispense Otezla, the new oral therapy for the treatment of adults with active psoriatic arthritis.

April 2, 2014

Sandoz on Tuesday announced the U.S. market introduction of its calcipotriene and betamethasone dipropionate ointment, the first generic version of Leo Pharma’s Taclonex Ointment.

March 31, 2014

Just days after the Food and Drug Administration approved Otezla, a new oral therapy to treat active psoriatic arthritis in adult patients, Avella Specialty Pharmacy on Friday announced that it is prepared to begin distributing the drug.

March 24, 2014

Celgene on Friday announced that the Food and Drug Administration has approved Otezla (apremilast), the company's oral, selective inhibitor of phosphodiesterase 4 (PDE4), for the treatment of adult patients with active psoriatic arthritis.

March 13, 2014

TriDerma, a provider in medical strength skin care products, has announced that its Facial Redness Repair and Psoriasis Control Skin Healing Creams are now available in California Target stores.

February 27, 2014

LED Technologies announced has formed an alliance with Kathy Ireland Worldwide to develop reVive Light Therapy skin care devices for anti-aging; uneven skin tone and hyperpigmantation; acne; and skin healing.

January 15, 2014

A new drug for autoimmune diseases from Antares Pharma that the company calls the first of its kind is now available, the drug maker said Wednesday.

January 14, 2014

Drug maker Sandoz has started a late-stage clinical trial of a biotech drug used to treat autoimmune disorders, the company said.

October 14, 2013

The Food and Drug Administration has approved a new drug made by Antares Pharma for treating rheumatoid arthritis and psoriasis, the drug maker said Monday.

October 7, 2013

The National Psoriasis Foundation and the Arthritis Foundation are presenting the country's first program specifically devoted to psoriatic arthritis this week, the two organizations said Monday.

September 30, 2013

The Food and Drug Administration has approved a new usage for a drug made by UCB, the drug maker said Monday.

September 23, 2013

The Food and Drug Administration has approved a drug made by Johnson & Johnson for psoriatic arthritis, the company said Monday.